Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even though the outcome of a late-stage trial has been delayed.
Source: https://www.marketwatch.com/story/a-delayed-clinical-trial-actually-boosted-bristol-myers-squibbs-stock-heres-why-b831896f?mod=mw_rss_topstories
About the Author
